What You Should Know:
- A new survey by the Center for Connected Medicine (CCM) at UPMC reveals that artificial intelligence (AI) continues to be a top priority for senior leaders in the healthcare industry.
- For the second year in a row, executives cited AI as both the most exciting technology and the most improved, highlighting its potential to transform healthcare.
Generative AI Takes Center Stage
The Top of Mind for Top Health Systems survey, conducted in
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
AISAP’s AI-Powered Cardiac Ultrasound Receives FDA Clearance
What You Should Know:
- AISAP, a medical technology company specializing in AI-powered point-of-care assisted diagnosis (POCAD) solutions, announced today that it has received FDA 510(k) clearance for its groundbreaking CARDIO software platform.
- AISAP CARDIO is a cloud-based software package that combines four computer-assisted diagnosis (CADx) modules for valvular pathologies and eight key measurements into a single, user-friendly platform.
Point-of-Care
Read More
Amp Health: A New Name for AI-Powered Workplace Injury Prevention
What You Should Know:
- Amp, the leading provider of AI-powered workplace injury prevention solutions, today unveiled a comprehensive brand refresh.
- The company is now known as Amp Health, reflecting its commitment to enhancing the health and well-being of industrial laborers.
A Unified Platform for Workplace Health
Amp Health offers a comprehensive suite of tools designed to address critical aspects of occupational health, including ergonomics, functional movement
Read More
Heart Health in the GLP-1 Era: The Role of Remote Patient Monitoring
According to the American Heart Association, nearly half of all adults in the U.S. have high blood pressure. Recent studies have suggested that effectively treating obesity with GLP-1 agonists may be key to improving overall heart health. These findings are promising — but additional study is necessary, further highlighting the need for accurate GLP-1 patient data and consistent at-home health monitoring.
Healthcare providers can benefit from high-precision remote monitoring tools like
Read More
CancerIQ Raises Growth Capital for Personalized Cancer Detection
What You Should Know:
- CancerIQ, a Chicago, IL-based precision health platform focused on empowering healthcare providers to personalize cancer prevention and early detection announced it has secured a growth funding package from Decathlon Capital Partners.
- While specific financial details of the transaction were not disclosed, the investment will enable CancerIQ to further develop its digital tools, introduce new offerings, and strengthen partnerships with healthcare
Read More
PreciseDx Raises $20.7M for AI-Powered Cancer Risk Assessments
What You Should Know:
- PreciseDx, a pioneering company in oncology diagnostics utilizing artificial intelligence (AI) raises $20.7M in Series B funding led by Eventide Asset Management with participation from Labcorp, Quest Diagnostics, GenHenn Capital Venture, and existing investors. This brings the company's total funding to date to $31.5M.
- The new funding will enable PreciseDx to accelerate its growth and expand its operations. The company plans to invest in talent
Read More
Piramidal Secures $6M to Expand Foundational AI Brain Model for Neurologists
What You Should Know:
- Upstart technology innovator Piramidal has secured $6 million in seed funding to aid its development of a barrier-breaking artificial intelligence (AI) model that will help neurologists assess brainwave data, with the potential to democratize analysis and shorten patient waiting time.
- The seed funding round attracted high-profile investors, including Y Combinator, Adverb Ventures, Lionheart Ventures, and angel investors such as founders of Intercom, Plangrid,
Read More
Ciba Health Unveils AI-Powered Disease Prevention Platform
What You Should Know:
- Ciba Health, a digital health company transforming healthcare with root-cause medicine and leveraging cutting-edge technology AI/ML, announced today its launch of Thrive by Ciba (Thrive), a data-powered, customizable disease prevention platform to help people live longer and healthier lives.
- Thrive offers deeply-personalized, comprehensive blood work, offering 100+ labs along with on-demand education to help members better understand their health and
Read More
GrayMatters Expands Footprint for Non-Invasive PTSD Treatment
What You Should Know:
- GrayMatters Health (GMH), developer of non-invasive treatments based on proprietary brain biomarkers associated with mental health disorders, today announced it is expanding its U.S. footprint with additional clinics now offering Prism for PTSD™ to patients.
- Prism for PTSD is the first prescribed self-neuromodulation device, cleared by the FDA to treat post-traumatic stress disorder (PTSD) as an adjunct to standard-of-care therapies.
Expansion of Prism
Read More
The Role of AI in Streamlining Drug Discovery and Clinical Trials: A New Era in Pharmaceutical Innovation
In the rapidly evolving world of pharmaceuticals, artificial intelligence (AI) is emerging as a game-changer. From accelerating drug discovery to enhancing the efficiency of clinical trials, AI is revolutionizing how new medicines are brought to market. This transformation is not just limited to the research and development phases; AI is also playing a critical role in ensuring that drugs meet regulatory standards.
The AI Revolution in Drug Discovery
Drug discovery has traditionally been a
Read More
